Mechanisms of accelerated liver fibrosis progression during HIV infection

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

With the introduction of antiretroviral therapy (ART), a dramatic reduction in HIV-related morbidity and mortality has been observed. However, it is now becoming increasingly clear that liver-related complications, particularly rapid fib-rosis development from ART as well as from the chronic HIV infection itself, are of serious concern to HIV patients. The pathophysiology of liver fibrosis in patients with HIV is a multifactorial process whereby persistent viral replication, and bacterial translocation lead to chronic immune activation and inflammation, which ART is unable to fully suppress, promoting production of fibrinogenic mediators and fibrosis. In addition, mitochondrial toxicity, triggered by both ART and HIV, contributes to intrahepatic damage, which is even more severe in patients co-infected with viral hepatitis. In recent years, new insights into the mechanisms of accelerated fibrosis and liver disease progression in HIV has been obtained, and these are detailed and discussed in this review.

Original languageEnglish (US)
Pages (from-to)328-335
Number of pages8
JournalJournal of Clinical and Translational Hepatology
Volume4
Issue number4
DOIs
StatePublished - 2016

Bibliographical note

Funding Information:
Funded in part by the Virgo consortium, the Dutch government (project number FES0908 to AB), the American College of Gastroenterology (CRA to JDD), and the United States’ National Institutes of Health (grant AI096925 to PRB).

Keywords

  • Bacterial translocation
  • HIV
  • Liver fibrosis
  • Mitochondrial toxicity

Fingerprint Dive into the research topics of 'Mechanisms of accelerated liver fibrosis progression during HIV infection'. Together they form a unique fingerprint.

Cite this